Posttranslational regulation of adherens junction stability and dissassembly

No Pathway Network information available for Posttranslational regulation of adherens junction stability and dissassembly

Pathways in the Posttranslational regulation of adherens junction stability and dissassembly SuperPath

#	Name	Source	Genes
1	Posttranslational regulation of adherens junction stability and dissassembly	PubChem	ABL1 ADAM10 ARF6 BDNF CABLES1 CASP3 CBLL1 CDH1 CDH2 CREBBP CTNNA1 CTNNB1 CTNND1 DNM2 DSP EGF EGFR FER FYN GDNF GFRA1 GNA12 HGS HRAS IGF1R IGF2 IQGAP1 JUP MEP1B MET MMP3 MMP7 NME1 NTRK2 NUTF2 PTPN1 PTPN6 RAB5A RAB7A RAC1 RET RIN2 ROBO1 SLIT1 SNX1 SRC TIAM1 ZBTB33 (see all 48) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	SNX1	Sorting Nexin 1	Protein Coding	1
2	NUTF2	Nuclear Transport Factor 2	Protein Coding	1
3	IGF2	Insulin Like Growth Factor 2	Protein Coding	1
4	MEP1B	Meprin A Subunit Beta	Protein Coding	1
5	RIN2	Ras And Rab Interactor 2	Protein Coding	1
6	FER	FER Tyrosine Kinase	Protein Coding	1
7	CDH2	Cadherin 2	Protein Coding	1
8	GFRA1	GDNF Family Receptor Alpha 1	Protein Coding	1
9	GDNF	Glial Cell Derived Neurotrophic Factor	Protein Coding	1
10	IGF1R	Insulin Like Growth Factor 1 Receptor	Protein Coding	1
11	NTRK2	Neurotrophic Receptor Tyrosine Kinase 2	Protein Coding	1
12	BDNF	Brain Derived Neurotrophic Factor	Protein Coding	1
13	EGF	Epidermal Growth Factor	Protein Coding	1
14	NME1	NME/NM23 Nucleoside Diphosphate Kinase 1	Protein Coding	1
15	CABLES1	Cdk5 And Abl Enzyme Substrate 1	Protein Coding	1
16	RAB5A	RAB5A, Member RAS Oncogene Family	Protein Coding	1
17	PTPN1	Protein Tyrosine Phosphatase Non-Receptor Type 1	Protein Coding	1
18	GNA12	G Protein Subunit Alpha 12	Protein Coding	1
19	PTPN6	Protein Tyrosine Phosphatase Non-Receptor Type 6	Protein Coding	1
20	MMP7	Matrix Metallopeptidase 7	Protein Coding	1
21	MMP3	Matrix Metallopeptidase 3	Protein Coding	1
22	IQGAP1	IQ Motif Containing GTPase Activating Protein 1	Protein Coding	1
23	CTNND1	Catenin Delta 1	Protein Coding	1
24	CBLL1	Cbl Proto-Oncogene Like 1	Protein Coding	1
25	CTNNB1	Catenin Beta 1	Protein Coding	1
26	CTNNA1	Catenin Alpha 1	Protein Coding	1
27	CDH1	Cadherin 1	Protein Coding	1
28	ZBTB33	Zinc Finger And BTB Domain Containing 33	Protein Coding	1
29	JUP	Junction Plakoglobin	Protein Coding	1
30	DSP	Desmoplakin	Protein Coding	1
31	CREBBP	CREB Binding Lysine Acetyltransferase	Protein Coding	1
32	ABL1	ABL Proto-Oncogene 1, Non-Receptor Tyrosine Kinase	Protein Coding	1
33	ADAM10	ADAM Metallopeptidase Domain 10	Protein Coding	1
34	TIAM1	TIAM Rac1 Associated GEF 1	Protein Coding	1
35	SLIT1	Slit Guidance Ligand 1	Protein Coding	1
36	ROBO1	Roundabout Guidance Receptor 1	Protein Coding	1
37	FYN	FYN Proto-Oncogene, Src Family Tyrosine Kinase	Protein Coding	1
38	MET	MET Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	1
39	RAB7A	RAB7A, Member RAS Oncogene Family	Protein Coding	1
40	RAC1	Rac Family Small GTPase 1	Protein Coding	1
41	ARF6	ARF GTPase 6	Protein Coding	1
42	HGS	Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate	Protein Coding	1
43	DNM2	Dynamin 2	Protein Coding	1
44	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	1
45	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
46	RET	Ret Proto-Oncogene	Protein Coding	1
47	EGFR	Epidermal Growth Factor Receptor	Protein Coding	1
48	CASP3	Caspase 3	Protein Coding	1

Disorders associated with Posttranslational regulation of adherens junction stability and dissassembly SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Colorectal cancer	Enrichment	CDH1, CTNNA1, CTNNB1, IGF2, MET, RET, SRC	7.68
2	Congenital central hypoventilation syndrome	Enrichment	BDNF, GDNF, RET	5.46
3	Renal agenesis, bilateral	Enrichment	GFRA1, RET, ROBO1	5.46
4	Lip and oral cavity carcinoma	Enrichment	ABL1, EGFR, HRAS	5.05
5	Blepharocheilodontic syndrome 1	Enrichment	CDH1, CTNND1	4.91
6	Childhood hepatocellular carcinoma	Enrichment	CTNNB1, MET	4.91
7	Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant	Enrichment	CDH2, DSP, JUP	4.83
8	Ovarian cancer	Enrichment	CDH1, CTNNB1, EGFR, MET, RET	4.56
9	Epidermolysis bullosa, lethal acantholytic	Enrichment	DSP, JUP	4.44
10	Hepatocellular carcinoma	Enrichment	CTNNB1, MET, RET	4.21
11	Diffuse gastric and lobular breast cancer syndrome	Enrichment	CDH1, CTNNA1	4.14
12	Inherited cancer-predisposing syndrome	Enrichment	CDH1, CTNNA1, EGFR, MET, RET	4.00
13	Bladder cancer	Enrichment	CTNNB1, EGFR, HRAS	3.85
14	Cleft lip with or without cleft palate	Enrichment	CDH1, CTNND1	3.74
15	Adult hepatocellular carcinoma	Enrichment	CTNNB1, EGF	3.36
16	Lung non-small cell carcinoma	Enrichment	EGFR, HRAS	3.18
17	Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant	Enrichment	DSP, JUP	3.10
18	Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant	Enrichment	DSP, JUP	3.10
19	Heart disease	Enrichment	ABL1, CREBBP	2.96
20	Corpus callosum, agenesis of	Enrichment	CDH2, CREBBP	2.90
21	Isolated corpus callosum agenesis	Enrichment	CDH2, CREBBP	2.90
22	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	CDH2, CREBBP	2.90
23	Arrhythmogenic right ventricular cardiomyopathy	Enrichment	DSP, JUP	2.85
24	Arteriovenous malformations of the brain	Enrichment	CDH2, EGFR	2.70
25	Multiple endocrine neoplasia, type iib	Enrichment	RET	2.45
26	Nystagmus 8, congenital, autosomal recessive	Enrichment	ROBO1	2.45
27	Arrhythmogenic right ventricular dysplasia, familial, 12	Enrichment	JUP	2.45
28	Hypomagnesemia 4, renal	Enrichment	EGF	2.45
29	Macular dystrophy, patterned, 2	Enrichment	CTNNA1	2.45
30	Charcot-marie-tooth disease, dominant intermediate b	Enrichment	DNM2	2.45
31	Naxos disease	Enrichment	JUP	2.45
32	Developmental and epileptic encephalopathy 58	Enrichment	NTRK2	2.45
33	Charcot-marie-tooth disease, axonal, type 2b	Enrichment	RAB7A	2.45
34	Charcot-marie-tooth disease type 2b	Enrichment	RAB7A	2.45
35	Osteofibrous dysplasia	Enrichment	MET	2.45
36	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	Enrichment	CDH2	2.45
37	Renal hypodysplasia/aplasia 4	Enrichment	GFRA1	2.45
38	Alzheimer disease 18	Enrichment	ADAM10	2.45
39	Deafness, autosomal recessive 97	Enrichment	MET	2.45
40	Autism 9	Enrichment	MET	2.45
41	Arrhythmogenic right ventricular dysplasia, familial, 14	Enrichment	CDH2	2.45
42	Coronary heart disease 6	Enrichment	MMP3	2.45
43	Lethal congenital contracture syndrome 5	Enrichment	DNM2	2.45
44	Reticulate acropigmentation of kitamura	Enrichment	ADAM10	2.45
45	Hirschsprung disease 3	Enrichment	GDNF	2.45
46	Obesity, hyperphagia, and developmental delay	Enrichment	NTRK2	2.45
47	Thrombocytopenia 6	Enrichment	SRC	2.45
48	Autosomal recessive congenital nystagmus	Enrichment	ROBO1	2.45
49	Menke-hennekam syndrome 1	Enrichment	CREBBP	2.45
50	Neurodevelopmental disorder with language delay and seizures	Enrichment	TIAM1	2.45
51	Pituitary hormone deficiency, combined or isolated, 8	Enrichment	ROBO1	2.45
52	Attention deficit-hyperactivity disorder 8	Enrichment	CDH2	2.45
53	Adenoid ameloblastoma	Enrichment	CTNNB1	2.45
54	Arthrogryposis, distal, type 11	Enrichment	MET	2.45
55	Neurooculorenal syndrome	Enrichment	ROBO1	2.45
56	Rubinstein-taybi syndrome due to 16p13.3 microdeletion	Enrichment	CREBBP	2.45
57	Skin fragility-woolly hair-palmoplantar keratoderma syndrome	Enrichment	DSP	2.45
58	Autosomal dominant charcot-marie-tooth disease type 2m	Enrichment	DNM2	2.45
59	Breast lobular carcinoma	Enrichment	CDH1	2.45
60	Thyroid cancer	Enrichment	RET	2.45
61	Vegetative pyoderma gangrenosum	Enrichment	PTPN6	2.45
62	Bullous pyoderma gangrenosum	Enrichment	PTPN6	2.45
63	Pustular pyoderma gangrenosum	Enrichment	PTPN6	2.45
64	Menke-hennekam syndrome	Enrichment	CREBBP	2.45
65	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.45
66	Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom	Enrichment	RAC1	2.45
67	Classic pyoderma gangrenosum	Enrichment	PTPN6	2.45
68	Egf-related primary hypomagnesemia with intellectual disability	Enrichment	EGF	2.45
69	Microcystic stromal tumor	Enrichment	CTNNB1	2.45
70	Gastrointestinal system disease	Enrichment	RET	2.45
71	Congenital nystagmus	Enrichment	ROBO1	2.45
72	Multiple endocrine neoplasia	Enrichment	RET	2.45
73	Tetralogy of fallot	Enrichment	RET, ROBO1	2.42
74	Hirschsprung disease 1	Enrichment	GDNF, RET	2.33
75	Differentiated thyroid carcinoma	Enrichment	HRAS, RET	2.33
76	Lung cancer	Enrichment	EGFR, MET	2.25
77	Costello syndrome	Enrichment	HRAS	2.15
78	Thumb deformity	Enrichment	CREBBP	2.15
79	Osteopathia striata with cranial sclerosis	Enrichment	CTNNB1	2.15
80	Arrhythmogenic right ventricular dysplasia, familial, 8	Enrichment	DSP	2.15
81	Silver-russell syndrome 3	Enrichment	IGF2	2.15
82	Keratosis palmoplantaris striata ii	Enrichment	DSP	2.15
83	Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	Enrichment	DSP	2.15
84	Blepharocheilodontic syndrome 2	Enrichment	CTNND1	2.15
85	Intellectual developmental disorder, autosomal dominant 48	Enrichment	RAC1	2.15
86	Congenital heart defects and skeletal malformations syndrome	Enrichment	ABL1	2.15
87	Acute myeloid leukemia with kat6a-crebbp fusion	Enrichment	CREBBP	2.15
88	Progressive familial heart block	Enrichment	DSP	2.15
89	Papillary renal cell carcinoma	Enrichment	MET	2.15
90	Cardiomyopathy, dilated, with woolly hair and keratoderma	Enrichment	DSP	2.15
91	Medullary thyroid carcinoma	Enrichment	RET	2.15
92	Juvenile nasopharyngeal angiofibroma	Enrichment	CTNNB1	2.15
93	Teratoma	Enrichment	CTNNB1	2.15
94	Silver-russell syndrome due to an imprinting defect of 11p15	Enrichment	IGF2	2.15
95	Wooly hair nevus	Enrichment	HRAS	2.15
96	Silver-russell syndrome due to 11p15 microduplication	Enrichment	IGF2	2.15
97	Microcephaly	Enrichment	ABL1, CTNNB1, IGF1R	2.03
98	Hereditary breast carcinoma	Enrichment	CDH1, RET	1.98
99	Desmoid disease, hereditary	Enrichment	CTNNB1	1.98
100	Thyroid carcinoma, familial medullary	Enrichment	RET	1.98
101	Myopathy, centronuclear, x-linked	Enrichment	DNM2	1.98
102	Neurodevelopmental disorder with spastic diplegia and visual defects	Enrichment	CTNNB1	1.98
103	Neutrophilic dermatosis, acute febrile	Enrichment	PTPN6	1.98
104	Neonatal nephrocutaneous inflammatory syndrome	Enrichment	EGFR	1.98
105	Anus, imperforate	Enrichment	CTNNB1	1.98
106	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige	Enrichment	DSP	1.98
107	Exudative vitreoretinopathy 7	Enrichment	CTNNB1	1.98
108	Woolly hair-skin fragility syndrome	Enrichment	DSP	1.98
109	Tethered spinal cord syndrome	Enrichment	CREBBP	1.98
110	Large congenital melanocytic nevus	Enrichment	HRAS	1.98
111	Desmoid tumor	Enrichment	CTNNB1	1.98
112	Keratosis palmoplantaris striata	Enrichment	DSP	1.98
113	Gingival overgrowth	Enrichment	RET	1.98
114	T-cell acute lymphoblastic leukemia	Enrichment	ABL1	1.98
115	Intraocular pressure quantitative trait locus	Enrichment	CREBBP	1.98
116	Spermatocytoma	Enrichment	HRAS	1.98
117	Butterfly-shaped pigment dystrophy	Enrichment	CTNNA1	1.98
118	Growth delay due to insulin-like growth factor i resistance	Enrichment	IGF1R	1.98
119	Neonatal inflammatory skin and bowel disease	Enrichment	EGFR	1.98
120	Renal cell carcinoma	Enrichment	MET	1.98
121	Beckwith-wiedemann syndrome due to imprinting defect of 11p15	Enrichment	IGF2	1.98
122	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS	1.85
123	Dowling-degos disease 1	Enrichment	ADAM10	1.85
124	Polyposis syndrome, hereditary mixed, 1	Enrichment	CTNNA1	1.85
125	Amyotrophy, monomelic	Enrichment	SLIT1	1.85
126	Pilomatrixoma	Enrichment	CTNNB1	1.85
127	Alazami syndrome	Enrichment	CTNNB1	1.85
128	Central hypoventilation syndrome, congenital, 1	Enrichment	RET	1.85
129	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	ABL1	1.85
130	Craniopharyngioma	Enrichment	CTNNB1	1.85
131	Epidermolytic nevus	Enrichment	HRAS	1.85
132	Silver-russell syndrome due to a point mutation	Enrichment	IGF2	1.85
133	Haddad syndrome	Enrichment	RET	1.85
134	Exudative vitreoretinopathy 1	Enrichment	CTNNB1	1.76
135	Multiple endocrine neoplasia, type iia	Enrichment	RET	1.76
136	Insulin-like growth factor i	Enrichment	IGF1R	1.76
137	Cardiac arrest	Enrichment	DSP	1.76
138	Myopathy, centronuclear, 1	Enrichment	DNM2	1.68
139	Cowden syndrome 1	Enrichment	EGFR	1.68
140	Weyers acrofacial dysostosis	Enrichment	CTNNB1	1.68
141	Rubinstein-taybi syndrome 1	Enrichment	CREBBP	1.68
142	Hemihyperplasia, isolated	Enrichment	IGF2	1.68
143	Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome	Enrichment	BDNF	1.68
144	Chromosome 16p13.3 deletion syndrome, proximal	Enrichment	CREBBP	1.68
145	Adrenocortical carcinoma	Enrichment	CTNNB1	1.68
146	Lung squamous cell carcinoma	Enrichment	EGFR	1.68
147	Hypertrichosis	Enrichment	CREBBP	1.68
148	Inherited arrhythmogenic cardiomyopathy	Enrichment	DSP	1.68
149	Sporadic pheochromocytoma/secreting paraganglioma	Enrichment	RET	1.68
150	Nevus, epidermal	Enrichment	HRAS	1.61
151	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS	1.61
152	Silver-russell syndrome 1	Enrichment	IGF2	1.61
153	Myelofibrosis	Enrichment	SRC	1.61
154	Squamous cell carcinoma, head and neck	Enrichment	EGFR	1.61
155	Leukemia, chronic myeloid	Enrichment	ABL1	1.61
156	Renal cell carcinoma, papillary, 1	Enrichment	MET	1.61
157	Noonan syndrome 3	Enrichment	HRAS	1.61
158	Gallbladder cancer	Enrichment	CTNNB1	1.61
159	Pilomyxoid astrocytoma	Enrichment	NTRK2	1.61
160	Follicular thyroid carcinoma	Enrichment	HRAS	1.61
161	Moyamoya angiopathy	Enrichment	ABL1	1.61
162	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	ABL1	1.61
163	Arthrogryposis, distal, type 1a	Enrichment	MET	1.55
164	Melanocytic nevus syndrome, congenital	Enrichment	HRAS	1.55
165	Renal hypodysplasia/aplasia 1	Enrichment	RET	1.55
166	Exudative vitreoretinopathy	Enrichment	CTNNB1	1.55
167	Hypothyroidism	Enrichment	RET	1.55
168	Myocarditis	Enrichment	DSP	1.55
169	Breast cancer	Enrichment	CDH1, RET	1.54
170	Arrhythmogenic right ventricular dysplasia, familial, 9	Enrichment	DSP	1.50
171	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	RAC1	1.50
172	Arteriovenous malformation	Enrichment	HRAS	1.50
173	Familial isolated arrhythmogenic right ventricular dysplasia	Enrichment	DSP	1.50
174	Dilated cardiomyopathy	Enrichment	DSP, JUP	1.49
175	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS	1.46
176	Cardiac conduction defect	Enrichment	DSP	1.38
177	Renal hypodysplasia/aplasia 3	Enrichment	RET	1.38
178	Aortic valve disease 1	Enrichment	DSP	1.35
179	Nk-cell enteropathy	Enrichment	IGF1R	1.35
180	Osteoporosis	Enrichment	SRC	1.31
181	Medulloblastoma	Enrichment	CTNNB1	1.31
182	Pheochromocytoma	Enrichment	RET	1.31
183	Lung cancer susceptibility 3	Enrichment	EGFR	1.31
184	Cleft lip/palate	Enrichment	CDH1	1.31
185	Pituitary stalk interruption syndrome	Enrichment	ROBO1	1.31
186	Renal cell carcinoma, nonpapillary	Enrichment	MET	1.29
187	Wilms tumor 1	Enrichment	IGF2	1.29
188	Rare genetic intellectual disability	Enrichment	CREBBP	1.29
189	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS	1.29
190	Congenital nervous system abnormality	Enrichment	CREBBP, CTNNB1	1.27
191	Nervous system disease	Enrichment	CREBBP, CTNNB1	1.27
192	Wolff-parkinson-white syndrome	Enrichment	JUP	1.26
193	Rhabdomyosarcoma	Enrichment	HRAS	1.26
194	Gliosarcoma	Enrichment	EGFR	1.26
195	Interstitial lung disease 2	Enrichment	DSP	1.23
196	Polycystic liver disease	Enrichment	CTNNB1	1.23
197	Giant cell glioblastoma	Enrichment	EGFR	1.23
198	Autosomal dominant polycystic liver disease	Enrichment	CTNNB1	1.23
199	Beckwith-wiedemann syndrome	Enrichment	IGF2	1.21
200	Diffuse large b-cell lymphoma	Enrichment	CREBBP	1.19
201	Macs syndrome	Enrichment	RIN2	1.16
202	Craniosynostosis	Enrichment	CTNNA1	1.16
203	Cardiomyopathy, dilated, 1a	Enrichment	DSP	1.14
204	Endometrial cancer	Enrichment	CDH1	1.14
205	Centronuclear myopathy	Enrichment	DNM2	1.14
206	Hepatoblastoma	Enrichment	CTNNB1	1.14
207	Hereditary paraganglioma-pheochromocytoma syndromes	Enrichment	RET	1.14
208	Cardiomyopathy, dilated, 1g	Enrichment	DSP	1.12
209	Noonan syndrome 1	Enrichment	HRAS	1.11
210	Precursor t-cell acute lymphoblastic leukemia	Enrichment	ABL1	1.11
211	Scoliosis	Enrichment	CREBBP	1.09
212	Hydrops fetalis, nonimmune	Enrichment	HRAS	1.05
213	Rasopathy	Enrichment	HRAS	1.05
214	Auditory neuropathy	Enrichment	CDH2	1.05
215	Prostate cancer	Enrichment	CDH1	1.01
216	Long qt syndrome 1	Enrichment	DSP	1.00
217	Long qt syndrome	Enrichment	DSP	0.98
218	Non-immune hydrops fetalis	Enrichment	HRAS	0.98
219	Cakut	Enrichment	ROBO1	0.94
220	Left ventricular noncompaction	Enrichment	DSP	0.93
221	Myopathy	Enrichment	DNM2	0.88
222	Charcot-marie-tooth disease	Enrichment	DNM2	0.87
223	Type 2 diabetes mellitus	Enrichment	PTPN1	0.86
224	Gastric cancer	Enrichment	CDH1	0.85
225	West syndrome	Enrichment	NTRK2	0.84
226	Sensorineural hearing loss	Enrichment	RET	0.80
227	Thrombocytopenia	Enrichment	SRC	0.80
228	Body mass index quantitative trait locus 11	Enrichment	BDNF	0.79
229	Hypertelorism	Enrichment	RET	0.77
230	Familial isolated dilated cardiomyopathy	Enrichment	DSP	0.77
231	Hereditary breast ovarian cancer syndrome	Enrichment	CTNNA1	0.75
232	Myeloma, multiple	Enrichment	CREBBP	0.74
233	Undetermined early-onset epileptic encephalopathy	Enrichment	NTRK2	0.74
234	Autism	Enrichment	CREBBP	0.65
235	Rare autosomal recessive non-syndromic sensorineural deafness type dfnb	Enrichment	MET	0.57
236	Complex neurodevelopmental disorder	Enrichment	TIAM1	0.45
237	Hereditary retinal dystrophy	Enrichment	CTNNA1	0.19
238	Fundus dystrophy	Enrichment	CTNNA1	0.19

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Posttranslational regulation of adherens junction stability and dissassembly

Pathway Network for Posttranslational regulation of adherens junction stability and dissassembly

Member Pathways for Posttranslational regulation of adherens junction stability and dissassembly

Pathways in the Posttranslational regulation of adherens junction stability and dissassembly SuperPath

Associated Genes for Posttranslational regulation of adherens junction stability and dissassembly

Associated Disorders for Posttranslational regulation of adherens junction stability and dissassembly

Disorders associated with Posttranslational regulation of adherens junction stability and dissassembly SuperPath

STRING Interaction Network for Posttranslational regulation of adherens junction stability and dissassembly

Sources for Posttranslational regulation of adherens junction stability and dissassembly